6-(2,2,2-trifluoroethylamino)-7-chloro-2, 3,4,5-tetrahydro-1H-benzo(d)azepine as a 5-HT2c receptor agonist
Details for Australian Patent Application No. 2004267027 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2005/019180 Priority application(s): WO2005/019180
2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004267030-Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser